Tang Capital Management LLC Nektar Therapeutics Transaction History

Tang Capital Management LLC

  • $1.33 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$0.42 - $0.57 $927,573 - $1.26 Million
2,208,509 Added 1582.03%
2,348,109 $1.31 Million
Q1 2023

May 15, 2023
SELL
$0.64 - $3.15 $15,737 - $77,458
-24,590 Reduced 14.98%
139,600 $97,000
Q4 2022

Feb 14, 2023
SELL
$2.03 - $4.28 $539,669 - $1.14 Million
-265,847 Reduced 61.82%
164,190 $371,000
Q1 2022

May 16, 2022
BUY
$4.16 - $13.72 $1.79 Million - $5.9 Million
430,037 New
430,037 $2.32 Million

Others Institutions Holding NKTR

# of Institutions
153
Shares Held
131M
Call Options Held
92.7K
Put Options Held
4.9K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $154M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Tang Capital Management LLC Portfolio

Follow Tang Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tang Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email